Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma
| Conditions: | Malignant Pleural Mesothelioma |
| Start Date: | September 1, 2004 |
| Phase: | Phase II |
| Status: | Completed |
| NCT ID: | NCT00272558 |
| Study Type: | Interventional |
| Intervention: | Drug: Carboplatin and Vinorelbine |
| Study Design: | Allocation: Non-Randomized|Control: Active Control|Endpoint Classification: Efficacy Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Rigshospitalet, Denmark |
| Ages: | Adult|Senior |
| Enrollment: | 40 |
| Funded By: | Other |
| First Received: | January 3, 2006 |
| End Date: | September 1, 2009 |
| Last Updated: | September 17, 2009 |
| Last Verified: | September 1, 2009 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
